Deregulated enhancer‐promoter communication in cancer through altered nuclear architecture
Abstract Enhancers are critical regulators of gene expression. Structural variations in cancer genomes can lead to enhancer hijacking, where oncogenes are activated by mistargeted enhancer activity. Novel enhancer‐promoter interactions may also arise through chromosomal rearrangements that create extrachromosomal DNA elements.
Isabelle Seufert+3 more
wiley +1 more source
Acute Myeloid Leukemia With <i>NPM1</i> Mutation Presenting With Rapidly Progressing Hypereosinophilia. [PDF]
Einarsdottir S+4 more
europepmc +1 more source
IMBALANCE IN NUCLEOTIDE POOLS OF MYELOID LEUKEMIA CELLS AND HL-60 CELLS: CORRELATION WITH CELL CYCLE PHASE,CELL PROLIFERATION AND DIFFERENTIATION: 53 [PDF]
D De Korte+3 more
openalex +1 more source
Somatic mutations precede acute myeloid leukemia years before diagnosis
Pinkal M. Desai+11 more
semanticscholar +1 more source
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar+2 more
wiley +1 more source
What's New? About half of penile squamous cell carcinomas are causally associated with inflammatory conditions such as lichen sclerosus (LSc), but few large‐scale studies have assessed the risk of penile cancer in men with LSc. Here, the authors conducted a large nationwide study in Denmark to estimate the risk of penile and non‐penile cancer in men ...
Marianne Gardar Stærk+5 more
wiley +1 more source
Acute Myeloid Leukemia with <i>NUP98::LNP1</i> Fusion Mimicking Chronic Myeloid Leukemia [PDF]
Wang H, Peng Y, Yang Z.
europepmc +1 more source
Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome [PDF]
TM McCarty+4 more
openalex +1 more source
What's New? Poor prognosis in cholangiocarcinoma (CCA) is attributed to late diagnosis and intrinsic chemoresistance. In particular, resistance mechanisms that suppress apoptosis limit the effectiveness of gemcitabine‐based regimens, which remain the standard treatment.
Wunan Mi+7 more
wiley +1 more source